arrow
R

Romain Palich

paris cité university and inserm and hôtel-dieu hospital
H指数:23
被引数:4,939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL)

HIV-1病毒学抑制患者转换为每日一次口服多拉韦林联合拉替拉韦的疗效与安全性:一项随机、开放标签、多中心Ⅱ期研究(DORAL)

2026-10-070
PRE
Lenacapavir Use in France: A National, Observational Study (LENAddOn)

LENAddOn研究:法国恩曲卡帕韦的使用情况——一项全国性观察性研究

2026-08-190
OAAI
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat’AIDS Cohort)

存档的M184V/I突变及换用多拉韦林、拉米夫定、富马酸替诺福韦二丙酯后病毒学失败的风险:一项国家观察性研究(Dat’AIDS队列)

2026-07-030
OA
High Uptake of HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men Recruited via Geosocial Networking Applications and Community Outreach in Paris, France

在巴黎,通过地理社交网络应用和社区外展招募的男男性行为者中,艾滋病病毒暴露前预防的高接受率

2026-06-080
PRE
Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir plus Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With Human Immunodeficiency Virus: Outcomes in Real-world Setting With and Without Tenofovir Resistance

在病毒学抑制的人类免疫缺陷病毒感染者中,将治疗方案转换为比克替拉韦/替诺福韦艾拉酚胺/恩曲他滨或多替拉韦加替诺福韦双福酸酯/恩曲他滨:有无替诺福韦耐药性的真实世界研究结果

2026-02-010
PRE
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable

尽管整合酶抑制剂在治疗HIV感染中的使用日益增多,但对该类药物的耐药性仍然稳定。

2025-12-010
PRE
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study

从依曲韦林转换为多拉韦林在病毒学抑制的HIV感染者中的疗效:法国多中心SWEED观察性研究的结果

2025-11-010
PRE
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

1997年至2018年间癌症风险和趋势,以及恢复的免疫力对HIV感染者的影响:来自ANRS CO4法国艾滋病医院数据库的结果

2025-11-010
OAAI
Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?

接受两药方案治疗的HIV感染者中急性乙型肝炎感染:我们能否信任其疫苗接种状态?

AIDS
IF3.1
2025-08-280
PRE
Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, France

2015-2022年抗逆转录病毒药物减量策略的采用及其对成本的影响:来自法国巴黎一家HIV诊所的经验

2025-08-010
PRE
Impact of COVID-19 and factors associated with long COVID and COVID-19 vaccine uptake in people with HIV in the United Kingdom: Results from Positive Voices 2022

COVID-19的影响以及与长期COVID和COVID-19疫苗接种率相关的因素:英国“积极声音2022”项目的研究结果

2025-05-010
OAAI
High incidence of pneumonia cases observed in children seen in general practice consultations during the 2023-2024 season, France

2023-2024季法国在普通实践咨询中观察到儿童肺炎病例的高发病率。

2025-03-250
OA
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs
2024-12-200
PRE
Engagement in Preexposure Prophylaxis Care at 1 Year Among Men Who Have Sex With Men Enrolled in the French ANRS PREVENIR Cohort Study
2024-12-200
OAAI